Literature DB >> 27622078

Nitric oxide synthase 2 is involved in the pro-tumorigenic potential of γδ17 T cells in melanoma.

Laetitia Douguet1, Lloyd Bod1, Renée Lengagne1, Laura Labarthe2, Masashi Kato3, Marie-Françoise Avril4, Armelle Prévost-Blondel1.   

Abstract

γδ T lymphocytes may exert either protective or tumor-promoting functions in cancer, mostly based on their polarization toward interferon (IFN)-γ or interleukin (IL)-17 productions, respectively. Here, we demonstrate that γδ T cells accelerate the spontaneous metastatic melanoma development in a model of transgenic mice for the human RET oncogene (Ret mice). We identify unanticipated roles of inducible nitric oxide synthase (NOS2) in favoring the recruitment of pro-tumor γδ T cells within the primary tumor. γδ T cells isolated from Ret mice deficient for NOS2 produced more IFNγ and less IL-17 than their counterparts from Ret mice. By supporting IL-17 production by γδ T cells, NOS2 leads to the recruitment of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) and metastasis formation. NOS2 also reduces the cytotoxicity of γδ T cells toward melanoma cells. Finally, we detected NOS2 expressing γδ T cells in the primary tumor and tumor-draining lymph nodes in Ret mice, but also in human melanoma. Overall our results support that this NOS2 autocrine expression is responsible for the polarization of γδ T cells toward a pro-tumor profile.

Entities:  

Keywords:  Interleukin 17; NOS2; melanoma; pro-tumor functions; γδ T cells

Year:  2016        PMID: 27622078      PMCID: PMC5007969          DOI: 10.1080/2162402X.2016.1208878

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN: 2162-4011            Impact factor:   8.110


  37 in total

1.  Regulation of cutaneous malignancy by gammadelta T cells.

Authors:  M Girardi; D E Oppenheim; C R Steele; J M Lewis; E Glusac; R Filler; P Hobby; B Sutton; R E Tigelaar; A C Hayday
Journal:  Science       Date:  2001-09-20       Impact factor: 47.728

2.  Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.

Authors:  D Massi; A Franchi; I Sardi; L Magnelli; M Paglierani; L Borgognoni; U Maria Reali; M Santucci
Journal:  J Pathol       Date:  2001-06       Impact factor: 7.996

3.  Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.

Authors:  Daiko Wakita; Kentaro Sumida; Yoichiro Iwakura; Hiroyoshi Nishikawa; Takayuki Ohkuri; Kenji Chamoto; Hidemitsu Kitamura; Takashi Nishimura
Journal:  Eur J Immunol       Date:  2010-07       Impact factor: 5.532

4.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

5.  Spontaneous vitiligo in an animal model for human melanoma: role of tumor-specific CD8+ T cells.

Authors:  Renée Lengagne; Frédérique-Anne Le Gal; Marylène Garcette; Laurence Fiette; Patrick Ave; Masashi Kato; Jean-Paul Briand; Christian Massot; Izumi Nakashima; Laurent Rénia; Jean-Gérard Guillet; Armelle Prévost-Blondel
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

6.  Transgenic mouse model for skin malignant melanoma.

Authors:  M Kato; M Takahashi; A A Akhand; W Liu; Y Dai; S Shimizu; T Iwamoto; H Suzuki; I Nakashima
Journal:  Oncogene       Date:  1998-10-08       Impact factor: 9.867

Review 7.  γδ T cells in cancer.

Authors:  Bruno Silva-Santos; Karine Serre; Håkan Norell
Journal:  Nat Rev Immunol       Date:  2015-10-09       Impact factor: 53.106

8.  The split nature of tumor-infiltrating leukocytes: Implications for cancer surveillance and immunotherapy.

Authors:  Telma Lança; Bruno Silva-Santos
Journal:  Oncoimmunology       Date:  2012-08-01       Impact factor: 8.110

9.  Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy.

Authors:  Yuting Ma; Laetitia Aymeric; Clara Locher; Stephen R Mattarollo; Nicolas F Delahaye; Pablo Pereira; Laurent Boucontet; Lionel Apetoh; François Ghiringhelli; Noëlia Casares; Juan José Lasarte; Goro Matsuzaki; Koichi Ikuta; Bernard Ryffel; Kamel Benlagha; Antoine Tesnière; Nicolas Ibrahim; Julie Déchanet-Merville; Nathalie Chaput; Mark J Smyth; Guido Kroemer; Laurence Zitvogel
Journal:  J Exp Med       Date:  2011-03-07       Impact factor: 14.307

10.  Gamma delta T cells provide an early source of interferon gamma in tumor immunity.

Authors:  Yunfei Gao; Wancai Yang; Meng Pan; Eileen Scully; Michael Girardi; Leonard H Augenlicht; Joe Craft; Zhinan Yin
Journal:  J Exp Med       Date:  2003-08-04       Impact factor: 14.307

View more
  13 in total

1.  IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma.

Authors:  Lloyd Bod; Renée Lengagne; Ludovic Wrobel; Jan Philipp Ramspott; Masashi Kato; Marie-Françoise Avril; Flavia Castellano; Valérie Molinier-Frenkel; Armelle Prévost-Blondel
Journal:  Oncoimmunology       Date:  2017-01-13       Impact factor: 8.110

2.  Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomas.

Authors:  Daniëlle Verver; Vichnou Poirier-Colame; Gorana Tomasic; Khadija Cherif-Rebai; Dirk J Grunhagen; Cornelis Verhoef; Stefan Suciu; Caroline Robert; Laurence Zitvogel; Alexander M M Eggermont
Journal:  Oncoimmunology       Date:  2019-09-06       Impact factor: 8.110

3.  SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.

Authors:  Priscilla S Redd; Mohammed L Ibrahim; John D Klement; Sarah K Sharman; Amy V Paschall; Dafeng Yang; Asha Nayak-Kapoor; Kebin Liu
Journal:  Cancer Res       Date:  2017-04-05       Impact factor: 12.701

4.  Inflammation drives nitric oxide synthase 2 expression by γδ T cells and affects the balance between melanoma and vitiligo associated melanoma.

Authors:  Laetitia Douguet; Lloyd Bod; Laura Labarthe; Renée Lengagne; Masashi Kato; Isabelle Couillin; Armelle Prévost-Blondel
Journal:  Oncoimmunology       Date:  2018-07-30       Impact factor: 8.110

Review 5.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

6.  Nitric Oxide Synthase 2 Improves Proliferation and Glycolysis of Peripheral γδ T Cells.

Authors:  Laetitia Douguet; Julien Cherfils-Vicini; Lloyd Bod; Renée Lengagne; Eric Gilson; Armelle Prévost-Blondel
Journal:  PLoS One       Date:  2016-11-03       Impact factor: 3.240

Review 7.  Regulation of iNOS on Immune Cells and Its Role in Diseases.

Authors:  Qingjie Xue; Yingchun Yan; Ruihua Zhang; Huabao Xiong
Journal:  Int J Mol Sci       Date:  2018-11-29       Impact factor: 5.923

Review 8.  The Role of Nitric Oxide in Cancer: Master Regulator or NOt?

Authors:  Faizan H Khan; Eoin Dervan; Dibyangana D Bhattacharyya; Jake D McAuliffe; Katrina M Miranda; Sharon A Glynn
Journal:  Int J Mol Sci       Date:  2020-12-10       Impact factor: 5.923

Review 9.  Regulation of T Cells in Cancer by Nitric Oxide.

Authors:  Inesa Navasardyan; Benjamin Bonavida
Journal:  Cells       Date:  2021-10-05       Impact factor: 6.600

Review 10.  Vγ9Vδ2 T Cells in the Bone Marrow of Myeloma Patients: A Paradigm of Microenvironment-Induced Immune Suppression.

Authors:  Barbara Castella; Myriam Foglietta; Chiara Riganti; Massimo Massaia
Journal:  Front Immunol       Date:  2018-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.